Most women still prefer clinic cervical screening over at-home self-sampling, despite home testing devices becoming available, a study has found. However, women who reported discrimination in...
Researchers have secured A$2.8m to test whether AI can better predict ovarian cancer survival and response to treatment. The grant will allow researchers to use AI...
Harmful bacteria may worsen breast cancer by switching on an enzyme that damages DNA and helps tumours grow, researchers say. The study found that pathogenic bacteria...
As of January 2026, the French health authorities have created a new “Safety and Environment Package” for hospitals (Package SE8), which includes the Magseed marker for...
Ovarian cancer cells quickly activate survival responses after PARP inhibitor treatment, and a lung cancer drug could help block this, research suggests. PARP inhibitors are a...
Agilent has FDA approval for a test to identify ovarian cancer patients who may be eligible for immunotherapy. Agilent’s PD-L1 IHC 22C3 pharmDx is the only...
Breakthroughs in cancer care don’t only come from large institutions or fully funded labs. They also come from determined individuals, small teams, early-stage founders, clinicians with...
An AI tool cut interval breast cancers by 12 per cent in a Swedish screening trial of more than 105,000 women. The study also found 27...
London’s shifting population is holding down breast screening uptake, experts have said, with the capital at 62.8 per cent in 2024, below the NHS’s acceptable 70...
Testing period blood for signs of cervical cancer could offer an accurate, convenient screening option for women who avoid clinic appointments, researchers say. The current NHS...
